Functional Annotation of the Human Retinal Pigment Epithelium
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
CREB-Binding Protein Regulates Lung Cancer Growth by Targeting MAPK and CPSF4 Signaling Pathway
MOLECULAR ONCOLOGY 10 (2016) 317e329 available at www.sciencedirect.com ScienceDirect www.elsevier.com/locate/molonc CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway Zhipeng Tanga,1, Wendan Yua,1, Changlin Zhangb,1, Shilei Zhaoa, Zhenlong Yua, Xiangsheng Xiaob, Ranran Tanga, Yang Xuana, Wenjing Yanga, Jiaojiao Haoa, Tingting Xua, Qianyi Zhanga, Wenlin Huangb,c, Wuguo Dengb,c,*, Wei Guoa,* aInstitute of Cancer Stem Cell, Dalian Medical University, Dalian, China bSun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China cState Key Laboratory of Targeted Drug for Tumors of Guangdong Province, Guangzhou Double Bioproduct Inc., Guangzhou, China ARTICLE INFO ABSTRACT Article history: CBP (CREB-binding protein) is a transcriptional co-activator which possesses HAT (histone Received 15 September 2015 acetyltransferases) activity and participates in many biological processes, including embry- Accepted 19 October 2015 onic development, growth control and homeostasis. However, its roles and the underlying Available online 5 November 2015 mechanisms in the regulation of carcinogenesis and tumor development remain largely unknown. Here we investigated the molecular mechanisms and potential targets of CBP Keywords: involved in tumor growth and survival in lung cancer cells. Elevated expression of CBP CBP was detected in lung cancer cells and tumor tissues compared to the normal lung cells CPSF4 and tissues. Knockdown of CBP by siRNA or inhibition of its HAT activity using specific hTERT chemical inhibitor effectively suppressed cell proliferation, migration and colony forma- Lung cancer tion and induced apoptosis in lung cancer cells by inhibiting MAPK and activating cyto- chrome C/caspase-dependent signaling pathways. -
Metallothionein Monoclonal Antibody, Clone N11-G
Metallothionein monoclonal antibody, clone N11-G Catalog # : MAB9787 規格 : [ 50 uL ] List All Specification Application Image Product Rabbit monoclonal antibody raised against synthetic peptide of MT1A, Western Blot (Recombinant protein) Description: MT1B, MT1E, MT1F, MT1G, MT1H, MT1IP, MT1L, MT1M, MT2A. Immunogen: A synthetic peptide corresponding to N-terminus of human MT1A, MT1B, MT1E, MT1F, MT1G, MT1H, MT1IP, MT1L, MT1M, MT2A. Host: Rabbit enlarge Reactivity: Human, Mouse Immunoprecipitation Form: Liquid Enzyme-linked Immunoabsorbent Assay Recommend Western Blot (1:1000) Usage: ELISA (1:5000-1:10000) The optimal working dilution should be determined by the end user. Storage Buffer: In 20 mM Tris-HCl, pH 8.0 (10 mg/mL BSA, 0.05% sodium azide) Storage Store at -20°C. Instruction: Note: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. Datasheet: Download Applications Western Blot (Recombinant protein) Western blot analysis of recombinant Metallothionein protein with Metallothionein monoclonal antibody, clone N11-G (Cat # MAB9787). Lane 1: 1 ug. Lane 2: 3 ug. Lane 3: 5 ug. Immunoprecipitation Enzyme-linked Immunoabsorbent Assay ASSP5 MT1A MT1B MT1E MT1F MT1G MT1H MT1M MT1L MT1IP Page 1 of 5 2021/6/2 Gene Information Entrez GeneID: 4489 Protein P04731 (Gene ID : 4489);P07438 (Gene ID : 4490);P04732 (Gene ID : Accession#: 4493);P04733 (Gene ID : 4494);P13640 (Gene ID : 4495);P80294 (Gene ID : 4496);P80295 (Gene ID : 4496);Q8N339 (Gene ID : 4499);Q86YX0 (Gene ID : 4490);Q86YX5 -
Mitochondrial Dynamics During Spermatogenesis Grigor Varuzhanyan and David C
© 2020. Published by The Company of Biologists Ltd | Journal of Cell Science (2020) 133, jcs235937. doi:10.1242/jcs.235937 REVIEW SUBJECT COLLECTION: MITOCHONDRIA Mitochondrial dynamics during spermatogenesis Grigor Varuzhanyan and David C. Chan* ABSTRACT Mitophagy is an additional layer of quality control that utilizes Mitochondrial fusion and fission (mitochondrial dynamics) are autophagy (Mizushima, 2007; Mizushima et al., 1998; Tsukada and homeostatic processes that safeguard normal cellular function. This Ohsumi, 1993) to remove excessive mitochondria or damaged relationship is especially strong in tissues with constitutively high energy mitochondria that are beyond repair (Pickles et al., 2018). During demands, such as brain, heart and skeletal muscle. Less is known about mitophagy, microtubule-associated protein 1A/1B light chain 3 the role of mitochondrial dynamics in developmental systems that involve (collectively LC3; also known as MAP1LC3A, MAP1LC3B and changes in metabolic function. One such system is spermatogenesis. MAP1LC3C) is recruited to the autophagosomal membrane and binds The first mitochondrial dynamics gene, Fuzzy onions (Fzo), was to mitochondria that selectively express mitophagy receptors on their discovered in 1997 to mediate mitochondrial fusion during Drosophila outer membrane. This molecular recognition designates damaged spermatogenesis. In mammals, however, the role of mitochondrial fusion mitochondria as cargo for autophagosomes, and the resulting during spermatogenesis remained unknown for nearly two decades after mitophagosomes subsequently fuse with lysosomes for degradation discovery of Fzo. Mammalian spermatogenesis is one of the most and recycling of the engulfed organelles. Much of the molecular complex and lengthy differentiation processes in biology, transforming workings of mitophagy have been parsed in cultured cells, and spermatogonial stem cells into highly specialized sperm cells over a recently developed mouse models are enabling the analysis of 5-week period. -
Natural Mutations Affect Structure and Function of Gc1q Domain of Otolin-1
International Journal of Molecular Sciences Article Natural Mutations Affect Structure and Function of gC1q Domain of Otolin-1 Rafał Hołubowicz * , Andrzej Ozyhar˙ and Piotr Dobryszycki * Department of Biochemistry, Molecular Biology and Biotechnology, Faculty of Chemistry, Wrocław University of Science and Technology, Wybrzeze˙ Wyspia´nskiego27, 50-370 Wrocław, Poland; [email protected] * Correspondence: [email protected] (R.H.); [email protected] (P.D.); Tel.: +48-71-320-63-34 (R.H.); +48-71-320-63-32 (P.D.) Abstract: Otolin-1 is a scaffold protein of otoliths and otoconia, calcium carbonate biominerals from the inner ear. It contains a gC1q domain responsible for trimerization and binding of Ca2+. Knowl- edge of a structure–function relationship of gC1q domain of otolin-1 is crucial for understanding the biology of balance sensing. Here, we show how natural variants alter the structure of gC1q otolin-1 and how Ca2+ are able to revert some effects of the mutations. We discovered that natural substitutions: R339S, R342W and R402P negatively affect the stability of apo-gC1q otolin-1, and that Q426R has a stabilizing effect. In the presence of Ca2+, R342W and Q426R were stabilized at higher Ca2+ concentrations than the wild-type form, and R402P was completely insensitive to Ca2+. The mutations affected the self-association of gC1q otolin-1 by inducing detrimental aggregation (R342W) or disabling the trimerization (R402P) of the protein. Our results indicate that the natural variants of gC1q otolin-1 may have a potential to cause pathological changes in otoconia and otoconial membrane, which could affect sensing of balance and increase the probability of occurrence of benign Citation: Hołubowicz, R.; Ozyhar,˙ paroxysmal positional vertigo (BPPV). -
BMC Genomics Biomed Central
BMC Genomics BioMed Central Research article Open Access Functional annotation of the human retinal pigment epithelium transcriptome Judith C Booij1, Simone van Soest1, Sigrid MA Swagemakers2,3, Anke HW Essing1, Annemieke JMH Verkerk2, Peter J van der Spek2, Theo GMF Gorgels1 and Arthur AB Bergen*1,4 Address: 1Department of Molecular Ophthalmogenetics, Netherlands Institute for Neuroscience (NIN), an institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), Meibergdreef 47, 1105 BA Amsterdam, the Netherlands (NL), 2Department of Bioinformatics, Erasmus Medical Center, 3015 GE Rotterdam, the Netherlands, 3Department of Genetics, Erasmus Medical Center, 3015 GE Rotterdam, the Netherlands and 4Department of Clinical Genetics, Academic Medical Centre Amsterdam, the Netherlands Email: Judith C Booij - [email protected]; Simone van Soest - [email protected]; Sigrid MA Swagemakers - [email protected]; Anke HW Essing - [email protected]; Annemieke JMH Verkerk - [email protected]; Peter J van der Spek - [email protected]; Theo GMF Gorgels - [email protected]; Arthur AB Bergen* - [email protected] * Corresponding author Published: 20 April 2009 Received: 10 July 2008 Accepted: 20 April 2009 BMC Genomics 2009, 10:164 doi:10.1186/1471-2164-10-164 This article is available from: http://www.biomedcentral.com/1471-2164/10/164 © 2009 Booij et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. -
Transcriptomic Analysis of the Aquaporin (AQP) Gene Family
Pancreatology 19 (2019) 436e442 Contents lists available at ScienceDirect Pancreatology journal homepage: www.elsevier.com/locate/pan Transcriptomic analysis of the Aquaporin (AQP) gene family interactome identifies a molecular panel of four prognostic markers in patients with pancreatic ductal adenocarcinoma Dimitrios E. Magouliotis a, b, Vasiliki S. Tasiopoulou c, Konstantinos Dimas d, * Nikos Sakellaridis d, Konstantina A. Svokos e, Alexis A. Svokos f, Dimitris Zacharoulis b, a Division of Surgery and Interventional Science, Faculty of Medical Sciences, UCL, London, UK b Department of Surgery, University of Thessaly, Biopolis, Larissa, Greece c Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece d Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, Larissa, Greece e The Warren Alpert Medical School of Brown University, Providence, RI, USA f Riverside Regional Medical Center, Newport News, VA, USA article info abstract Article history: Background: This study aimed to assess the differential gene expression of aquaporin (AQP) gene family Received 14 October 2018 interactome in pancreatic ductal adenocarcinoma (PDAC) using data mining techniques to identify novel Received in revised form candidate genes intervening in the pathogenicity of PDAC. 29 January 2019 Method: Transcriptome data mining techniques were used in order to construct the interactome of the Accepted 9 February 2019 AQP gene family and to determine which genes members are differentially expressed in PDAC as Available online 11 February 2019 compared to controls. The same techniques were used in order to evaluate the potential prognostic role of the differentially expressed genes. Keywords: PDAC Results: Transcriptome microarray data of four GEO datasets were incorporated, including 142 primary Aquaporin tumor samples and 104 normal pancreatic tissue samples. -
A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated. -
Proteome and Secretome Dynamics of Human Retinal Pigment Epithelium in Response to Reactive Oxygen Species Jesse G
www.nature.com/scientificreports OPEN Proteome and Secretome Dynamics of Human Retinal Pigment Epithelium in Response to Reactive Oxygen Species Jesse G. Meyer 1,2*, Thelma Y. Garcia1, Birgit Schilling 1, Bradford W. Gibson1,3 & Deepak A. Lamba 1,4* Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries, and is characterized by slow retinal degeneration linked to chronic reactive oxygen species (ROS) in the retinal pigmented epithelium (RPE). The molecular mechanisms leading to RPE dysfunction in response to ROS are unclear. Here, human stem cell-derived RPE samples were stressed with ROS for 1 or 3 weeks, and both intracellular and secreted proteomes were quantifed by mass spectrometry. ROS increased glycolytic proteins but decreased mitochondrial complex I subunits, as well as membrane proteins required for endocytosis. RPE secreted over 1,000 proteins, many of which changed signifcantly due to ROS. Notably, secreted APOE is decreased 4-fold, and urotensin-II, the strongest known vasoconstrictor, doubled. Furthermore, secreted TGF-beta is increased, and its cognate signaler BMP1 decreased in the secretome. Together, our results paint a detailed molecular picture of the retinal stress response in space and time. AMD is the leading cause of blindness in people over age 50, and represents an area of signifcant unmet clin- ical need. AMD is characterized by retinal degeneration in the center of the retina, the macula. Tree tissues comprise a minimally functional unit of the retina, RPE is the epithelial layer between the light-sensitive photo- receptors (PRs) and vasculature (choroid). RPE is especially important among this triplet because it forms the outer blood-retinal barrier due to the tight-junctions between the cells. -
Identification of the Gene and Mutation for Progressive Rod-Cone Degeneration in Dog and Method for Testing Same
Europäisches Patentamt *EP001609876A1* (19) European Patent Office Office européen des brevets (11) EP 1 609 876 A1 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.7: C12Q 1/68 28.12.2005 Bulletin 2005/52 (21) Application number: 05253831.1 (22) Date of filing: 21.06.2005 (84) Designated Contracting States: • Zangerl, Barbara AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Philadelphia, PA 19104 (US) HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR • Goldstein, Orly Designated Extension States: Ithaca, NY 14850 (US) AL BA HR LV MK YU • Pearce-Kelling, Susan Berkshire, NY 13736 (US) (30) Priority: 21.06.2004 US 581499 P • Felix, Jeanette S. Horseheads, NY 14845 (US) (71) Applicant: CORNELL RESEARCH FOUNDATION, • Sidjanin, Duska J. INC. Brookfield, WI 53045 (US) Ithaca, NY 14850 (US) (74) Representative: MacLean, Martin Robert et al (72) Inventors: Mathys & Squire • Aguirre, Gustavo 120 Holborn Philadelphia, PA 19151 (US) London EC1N 2SQ (GB) • Acland, Gregory M. Unionville, PA 19375 (US) (54) Identification of the gene and mutation for progressive rod-cone degeneration in dog and method for testing same (57) Tools and methods are provided for determin- tion of a transversion from G to A at position correspond- ing whether or not a dog is genetically normal, is a carrier ing to nucleotide position 1298 of SEQ ID NO: 1. of, or is affected with or predisposed to progressive rod- cone degeneration. The method is based on the detec- EP 1 609 876 A1 Printed by Jouve, 75001 PARIS (FR) EP 1 609 876 A1 Description FIELD OF THE INVENTION 5 [0001] The present invention relates generally to a class of genetic diseases, observed in canines, termed progres- sive rod-cone degeneration ("prcd"). -
Common MFRP Sequence Variants Are Not Associated with Moderate to High Hyperopia, Isolated Microphthalmia, and High Myopia
Molecular Vision 2008; 14:387-393 <http://www.molvis.org/molvis/v14/a47> © 2008 Molecular Vision Received 12 December 2007 | Accepted 6 February 2008 | Published 4 March 2008 Common MFRP sequence variants are not associated with moderate to high hyperopia, isolated microphthalmia, and high myopia Ravikanth Metlapally,1,2 Yi-Ju Li,2 Khanh-Nhat Tran-Viet,2 Anuradha Bulusu,2 Tristan R. White,2 Jaclyn Ellis, 2 Daniel Kao,2 Terri L. Young1,2 1Duke University Eye Center, Durham, NC; 2Duke University Center for Human Genetics, Durham, NC Purpose: The membrane-type frizzled-related protein (MFRP) gene is selectively expressed in the retinal pigment epithelium and ciliary body, and mutations of this gene cause nanophthalmos. The MFRP gene may not be essential for retinal function but has been hypothesized to play a role in ocular axial length regulation. The involvement of the MFRP gene in moderate to high hyperopic, isolated microphthalmic/anophthalmic, and high myopic patients was tested in two phases: a mutation screening/sequence variant discovery phase and a genetic association study phase. Methods: Eleven hyperopic, ten microphthalmic/anophthalmic, and seven non-syndromic high-grade myopic patients of varying ages and 11 control subjects participated in the mutation screening phase. Sixteen primer pairs were designed to amplify the 13 exons of the MFRP gene including intron/exon boundaries. Polymerase chain reactions were performed, and amplified products were sequenced using standard techniques. Normal and affected individual DNA sequences were compared alongside the known reference sequence (UCSC genome browser) for the MFRP gene. The genetic association study included 146 multiplex non-syndromic high-grade myopia families. -
The Genetic and Clinical Landscape of Nanophthalmos in an Australian
medRxiv preprint doi: https://doi.org/10.1101/19013599; this version posted December 4, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . 1 The genetic and clinical landscape of nanophthalmos in an Australian cohort 2 3 Running title: Genetics of nanophthalmos in Australia 4 5 Owen M Siggs1, Mona S Awadalla1, Emmanuelle Souzeau1, Sandra E Staffieri2,3,4, Lisa S Kearns2, Kate 6 Laurie1, Abraham Kuot1, Ayub Qassim1, Thomas L Edwards2, Michael A Coote2, Erica Mancel5, Mark J 7 Walland6, Joanne Dondey7, Anna Galanopoulous8, Robert J Casson8, Richard A Mills1, Daniel G 8 MacArthur9,10, Jonathan B Ruddle2,3,4, Kathryn P Burdon1,11, Jamie E Craig1 9 10 1Department of Ophthalmology, Flinders University, Adelaide, Australia 11 2Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 12 3Department of Ophthalmology, University of Melbourne, Melbourne, Australia 13 4Department of Ophthalmology, Royal Children’s Hospital, Melbourne, Australia 14 5Centre Hospitalier Territorial de Nouvelle-Calédonie, Noumea, New Caledonia 15 6Glaucoma Investigation and Research Unit, Royal Victorian Eye and Ear Hospital, Melbourne, Australia 16 7Royal Victorian Eye and Ear Hospital, Melbourne, Australia 17 8Discipline of Ophthalmology & Visual Sciences, University of Adelaide, Adelaide, Australia 18 9Program in Medical and Population -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase